CLINICAL_TRIALS
trial_result
· 2021-02-26
Clinical Trial Update: Tanezumab in Osteoarthritis Of The Hip [Phase 3]
Summary
Phase 3 trial update for tanezumab in osteoarthritis of the hip; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Arthritis, Osteoarthritis | Phase 3 | Status: COMPLETED | Results posted: 2021-02-26